中西药结合治疗慢性前列腺炎疗效分析

摘要] 目的 探讨中西医结合治疗慢性前列腺炎的临床疗效。 方法 96例患者符合美国国立卫生研究院(NIH)制定的慢性前列腺炎诊断标准，分为西医治疗组（I组，48例）和中西医结合治疗组（II组，48例），I组口服左氧氟沙星与特拉唑嗪，II组在I组的基础上加服中药前列康汤，治疗6～8周后，按慢性前列腺炎症状评分（NIH-CPSI）和前列腺液白细胞计数(EPS-WBC)评估疗效。结果 I,II组NIH-CPSI分别为(13.2±4.8)分和(10.3±4.3)分，较治疗前均显著下降(P＜0.01)，治疗后两组NIH-CPSI与EPS-WBC均有显著性差异(P＜0.05)；I,II组总有效率分别为79.2%和93.8%，差异有统计学意义(P＜0.05)；不良反应发生率分别为10.4%和4.2%。结论 中西医结合治疗慢性前列腺炎疗效显著，可明显改善症状，提高生活质量，且不良反应少。 关键词] 前列康汤 慢性前列腺炎 中西医结合治疗 。

Therapeutic effects of traditional Chinese medicine and western medicine for treatment of Chronic Prostatitis

Objective] To explore the clinical efficacy of the combination of traditional Chinese medicine and western medicine in the treatment of chronic prostatitis. Methods] 96 cases of patients who diagnosed as chronic prostatitis according to the criteria of American National Institute Health(NIH) were included, 48 cases were treated with the combination of Levofloxacin and Terazosin(group I), and the other 48 cases were treated with the combination of Levofloxacin, Terazosin and Qianliekan(group II) for 6-8 weeks. The efficacy was evaluated by the expressed prostatic secretions(EPS)leukocyte(WBC)count and NIH chronic prostatitis symptom index（NIH-CPSI）before and after treatment.Results] The NIH-CPSI scores were(13.2±4.8)in group I and(10.3±4.3)in group II, which showed significantly lower than before treatment(P＜0.01). There were significant differences both in the NIH-CPSI and EPS-WBC between these two groups after treatment(P＜0.05). The total effective rates were 93.8% in group II, compared with group I(79.2%), it has the statistical value（P＜0.05）. The incidence of adverse reactions were 4.2% in group II and 10.4% in group I. Conclusion] The combination of traditional Chinese medicine and western medicine have significantly effect in the treatment of chronic prostatitis. Compared with the western medicine only therapy, the combination therapy could obviously improve the symptoms and the quality of life, and has few side effects, which could be an ideal therapy for chronic prostatitis.